(NASDAQ: PEPG) Pepgen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.
Pepgen's earnings in 2026 is -$89,655,000.On average, 9 Wall Street analysts forecast PEPG's earnings for 2026 to be -$93,658,132, with the lowest PEPG earnings forecast at -$141,561,941, and the highest PEPG earnings forecast at -$63,136,819. On average, 7 Wall Street analysts forecast PEPG's earnings for 2027 to be -$77,263,985, with the lowest PEPG earnings forecast at -$94,826,181, and the highest PEPG earnings forecast at -$48,622,608.
In 2028, PEPG is forecast to generate -$42,651,047 in earnings, with the lowest earnings forecast at -$50,799,740 and the highest earnings forecast at -$33,382,686.